MARRONE BIO INNOVATIONS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENTForegoing Agreement • July 1st, 2013 • Marrone Bio Innovations Inc • Agricultural chemicals • California
This Convertible Note Purchase Agreement (the “Agreement”) is made this 15th day of March, 2012, by and among Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), and the Investors listed on the Schedule of Investors attached hereto as Exhibit A (the “Investors”).
Steerpike, Inc. c/o RZO 250 West 57th Street New York, NY 10017Foregoing Agreement • August 14th, 2003 • SLS International Inc • Pumps & pumping equipment • New York
Abengoa, S.A. Registration Rights AgreementForegoing Agreement • July 2nd, 2015 • Abengoa Yield PLC • Electric services • New York
Abengoa, S.A., a company incorporated under the laws of the Kingdom of Spain, having its registered office at Campus Palmas Altas, calle Energía, 41014 Seville, Spain (the “Issuer”), proposes to issue and sell to certain managers (the “Managers”) its 5.125% Exchangeable Notes due 2017 (the “Notes”), upon the terms set forth in the Subscription Agreement by and among the Issuer and the Managers, dated as of February 26, 2015 (the “Subscription Agreement”), relating to the subscription (the “Subscription”) of the Notes. In certain circumstances, the Notes will be exchangeable for ordinary shares, par value $0.10 per share (the “Common Stock”), of Abengoa Yield plc, a public limited company incorporated under the laws of England and Wales (the “Company”), in accordance with the terms of the Notes and the Agency Agreement (as defined below). To induce the Managers to enter into the Subscription Agreement and to satisfy their obligations thereunder, the holders of the Notes will have the be
MARRONE BIO INNOVATIONS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENTForegoing Agreement • June 17th, 2013 • Marrone Bio Innovations Inc • Agricultural chemicals
This Convertible Note Purchase Agreement (the “Agreement”) is made this 15th day of March, 2012, by and among Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), and the Investors listed on the Schedule of Investors attached hereto as Exhibit A (the “Investors”).
